Document is current
Any future updates will be listed below
-
Authors
Wang, Shan
Zhang, You
Qi, Datun
Wang, Xianpei
Zhu, Zhongyu
Yang, Wei
Li, Muwei
Hu, Dayi
Gao, Chuanyu
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02641262 at ClinicalTrials.govDocuments that mention this clinical trial
Development and validation of a risk score for predicting 30-day mortality in patients with ST elevation myocardial infarction
https://doi.org/10.1038/s41598-025-92615-3
Reperfusion strategy and in-hospital outcomes for ST elevation myocardial infarction in secondary and tertiary hospitals in predominantly rural central China: a multicentre, prospective and observational study
https://doi.org/10.1136/bmjopen-2021-053510
-
Funding
Funding for this research was provided by:
Health and Family Planning Commission of Henan Province (LHGJ20210105)
Science and Technology Department of Henan Province (222102310656)
Henan Young and Middle-aged Health Science and Technology Innovation Outstanding Talent Project (YXKC2021028)
Henan Science and Technology Project (212102310792)
Fuwai Henan Hospital, Chinese Academy of Medical Sciences
Henan Key Research and Development Project (241111312200)
- License Information
-
More Information
Article History
Received: 4 June 2024
Accepted: 3 March 2025
First Online: 15 March 2025
Declarations
:
: The authors declare no competing interests.
: Due to the nature of the study, the Ethics Committee of Henan Provincial People’s Hospital waived the need of obtaining informed consent [NO. 2015 (34)]. Meanwhile, all the treatments applied to participants were in accordance with relevant guidelines and the Declaration of Helsinki, and no additional intervention was applied, and the other 65 participating institutes were covered by central ethics approval.
